ctgct.bsky.social
Focused on cancer and rare diseases. Project: 101059842 - CTGCT - HORIZON-WIDERA-2022. Co-funded by the European Union, the UK Research and Innovation (UKRI) and European Regional Development Fund EU under Slovenia’s Cohesion Policy Programme 2021-2027.
👤 Joined on 13 December 2024
Followers
Following
Total Posts
@ctgct.bsky.socialLung neuroendocrine cancer induces immunosuppressive macrophages via serotonin to drive resistance to the T cell engager tarlatamab @cp-cancercell.bsky.social www.cell.com/cancer-cell/...
Show Post@kemijski.bsky.social @ucltro.bsky.social @umcutrecht.bsky.social @tudresden.bsky.social @bihatcharite.bsky.social #CTGCTDay2026 #ATMP #GeneTherapy #CellTherapy #TranslationalResearch
Show Post📢 The final program for #CTGCTDay2026 is now available! Join experts from academia, industry, and other institutions to discuss the latest advances in cell, tissue, and gene therapies. 📅 11/11/ 2026, Ljubljana ✅ Free registration ⚠️ 25 Seats left Programme: ctgct.si/en/ctgct-day...
Show PostWhat if a vaccine could help tackle high cholesterol? At #CTGCTDay2026, Špela Malenšek (@kemijski.bsky.social ) will present her work on: “Immunoengineering genetically encoded chimeric PCSK9 vaccine against hypercholesterolemia” Free registration: forms.cloud.microsoft/e/inxvq4Kbyc
Show PostWhat if we could control cells with pulses of light?💡 The 2026 #NobelPrize #Medicine honors #optogenetics, a discovery that changed neuroscience and is now shaping synthetic biology, regenerative medicine, and gene & cell therapies. And the story doesn't stop with light.👀 ctgct.si/en/objave/im...
Show Post